1461 studies found for:    "Sexually Transmitted Diseases, Viral"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
2 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
3 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
4 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
5 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
6 Terminated The Mochudi Prevention Project ART Protocol
Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
7 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
8 Not yet recruiting Antiviral Pharmacology and Adherence in Drug Users
Conditions: HEPATITIS C;   Virus, Human Immunodeficiency
Interventions: Behavioral: Directly Observed Therapy;   Behavioral: Wirelessly Observed Therapy
9 Not yet recruiting A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients
Conditions: Human Immunodeficiency Virus;   Dolutegravir;   Monotherapy;   Treatment Efficacy
Intervention: Drug: Dolutegravir
10 Completed Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men
Conditions: Human Immunodeficiency Virus (HIV);   Sexually Transmitted Disease (STD)
Interventions: Behavioral: STAND HIV Risk Reduction Intervention;   Behavioral: Text Messaging Intervention
11 Recruiting A Sleep Program to Improve Sleep Quality in People With HIV
Conditions: HIV - Human Immunodeficiency Virus;   Insomnia Disorder
Intervention: Behavioral: Digital cognitive behavioural therapy for insomnia (dCBT-I)
12 Recruiting Cognitive Training for the Remediation of Functional Brain Health in HIV
Conditions: HIV - Human Immunodeficiency Virus;   Cognitive Impairment
Intervention: Behavioral: Plasticity-based Adaptive Cognitive Remediation (PACR)
13 Completed A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) Infection
Condition: HIV Infections
Intervention: Drug: enfuvirtide
14 Not yet recruiting Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults
Condition: Healthy
Interventions: Biological: Ad26.ZEBOV;   Biological: MVA-BN-Filo;   Biological: Placebo
15 Recruiting Targeting Effective Analgesia in Clinics for HIV - Intervention
Conditions: HIV Infection;   Pain;   Drug Dependence
Interventions: Behavioral: Collaboration with an IT enabled nurse care manager;   Behavioral: Education and academic detailing;   Behavioral: Facilitated access to a specialist in addictions
16 Completed Being Responsible for Ourselves HIV Risk Reduction for Black MSM
Conditions: Human Immunodeficiency Virus Infection (HIV);   Sexually Transmitted Disease (STD)
Interventions: Behavioral: BRO HIV Risk Reduction Intervention;   Behavioral: Health Promotion Intervention
17 Recruiting Safety and Efficacy of Emtricitabine/Tenofovir Alafenamide as Part of Salvage Antiretroviral Regimens in Patients With Uncontrolled Viremia and Drug-Resistant HIV Infection
Conditions: HIV;   HBV
Intervention: Drug: Emtricitabine 200mg/tenofovir alafenamide 25 mg (F/TAF)
18 Not yet recruiting Interaction With HIV Antiretroviral Agents
Condition: HIV-DDI
Interventions: Drug: Riociguat (ADEMPAS);   Drug: ATRIPLA;   Drug: COMPLERA;   Drug: STRIBILD;   Drug: TRIUMEQ;   Drug: Antiretroviral protease inhibitor
19 Not yet recruiting A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)
Condition: Hepatitis C
Interventions: Drug: Daclatasvir;   Drug: Sofosbuvir
20 Recruiting Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection
Conditions: HIV Infections;   Chikungunya Virus Infection
Intervention: Other: Biological sample collection

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years